This aspect has a strong relevance in the case of Triple-negative subtype of BC, being that, due to the negative nature of the three major receptors (ER, PR and HER2), its treatment stands mainly on the conventional chemotherapy. This evidence concerns the gene ERBB2 and breast cancer.